The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

about

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

Item

http://www.wikidata.org/entity/Q47686082

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

@en

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

@nl

type

Item

label

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

@en

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

@nl

prefLabel

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

@en

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

@nl

P1476

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel

@en

P2093

Eitan Friedman

http://www.w3.org/2001/XMLSchema#string

Hagit Schayek

http://www.w3.org/2001/XMLSchema#string

Jamal Zidan

http://www.w3.org/2001/XMLSchema#string

Orit Reish

http://www.w3.org/2001/XMLSchema#string

Sara Haim

http://www.w3.org/2001/XMLSchema#string

Shira Lotan

http://www.w3.org/2001/XMLSchema#string

Yael Laitman

http://www.w3.org/2001/XMLSchema#string

P2860

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

Limited family structure and BRCA gene mutation status in single cases of breast cancer.

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface.

Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel.

Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.

Two BRCA1/2 founder mutations in Jews of Sephardic origin.

The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil.

P2888

s10549-017-4551-7

P304

697-702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-017-4551-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P50

Rinat Bernstein

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29086229

http://www.w3.org/2001/XMLSchema#string

P921

Israel